Every state, kept current
The Rates plan
$29/mo7-day free trialThis page shows one representative rate per state for J2787. Full schedules include every locality, modifier, and age-band variant.
- Every code on all 51 published schedules
- Full-schedule CSV export and state network lists
- Email alerts when a state changes its rates
$29/mo after the trial. Cancel anytime.
Publishing states
16
Median % of Medicare
--
Rate range
$725.41 - $2,435.04
J2787 rates in every publishing state
| State | Medicaid rate | % of Medicare | Prior auth | Vintage |
|---|---|---|---|---|
| Arizona | $2,280.00 | -- | -- | 2026 |
| California | $2,280.00 | -- | -- | 2026 |
| Indiana | $2,394.00 | -- | Required | 2024 |
| Kansas | $2,280.00 | -- | -- | 2026 |
| Louisiana | $2,280.00 | -- | -- | 2026 |
| Maine | $725.41 | -- | -- | 2026 |
| Minnesota | $2,280.00 | -- | -- | 2025 |
| Mississippi | $2,280.00 | -- | -- | 2025 |
| Montana | $2,075.00 | -- | -- | 2026 |
| Nebraska | $2,435.04 | -- | -- | 2026 |
| New Hampshire | $2,280.00 | -- | Not required | 2026 |
| New Mexico | $2,280.00 | -- | -- | 2025 |
| Oklahoma | $2,280.00 | -- | -- | 2026 |
| South Carolina | $2,243.52 | -- | -- | 2025 |
| Texas | $2,325.60* | -- | -- | 2025 |
| Utah | $2,280.00* | -- | Not required | 2026 |
Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. Rows marked * are representative published variants or methodology-derived rates. "--" in the prior-auth column means the state publishes no PA flag.
Related drugs codes
- J0013 - Esketamine, nasal spray, 1 mg
- J0120 - Injection, tetracycline, up to 250 mg
- J0121 - Injection, omadacycline, 1 mg
- J0122 - Injection, eravacycline, 1 mg
- J0129 - Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- J0130 - Injection abciximab, 10 mg
- J0131 - Injection, acetaminophen, not otherwise specified,10 mg
- J0132 - Injection, acetylcysteine, 100 mg
All 157 codes from J2002 to J2998 or every drugs code by number.
Frequently asked questions
How much does Medicaid pay for J2787?
16 state Medicaid programs publish a fee-for-service rate for J2787 (riboflavin 5'-phosphate, ophthalmic solution (photrexa viscous/photrexa), up to 3 ml), ranging from $725.41 in Maine to $2,435.04 in Nebraska. The full table on this page lists every publishing state's current rate.
Which state pays the most for J2787?
Nebraska publishes the highest Medicaid rate for J2787 at $2,435.04. Maine publishes the lowest at $725.41.
Does J2787 require prior authorization under Medicaid?
1 of the 16 publishing states flag J2787 as requiring prior authorization (always or conditionally) on their fee schedules. States without a flag publish no PA indicator for this code - that means "not published", not "no PA required".